Back to Insider Trading View Full Company Profile

TSHA

UNKNOWN

Taysha Gene Therapies, Inc.

CIK: 0001806310

Strong Sell (90% confidence)

Last activity: 1 weeks ago

Financial Metrics

As of Dec 31, 2024 (10-K)

Revenue $8.33M
Total Cash $139.04M

Insider Roster (3 total, 3 active)

Insider Buys Sells Net Value Holdings
Nagendran Sukumar
President and Head of R&D
0 5 -$3.19M
1,317,389 shares
$6.07M
Nolan Sean P.
Chief Executive Officer
0 2 -$840K
2,908,257 shares
$13.41M
Alam Kamran
CHIEF FINANCIAL OFFICER
0 3 -$493K
1,442,131 shares
$6.52M

Recent Transactions

SELL Alam Kamran (CHIEF FINANCIAL OFFICER)

1,655 shares @ $4.52

$7K

Feb 4, 2026

Conviction: | View SEC Filing →
SELL Nolan Sean P. (Chief Executive Officer)

41,312 shares @ $4.61

$190K

Jan 26, 2026

Conviction: | View SEC Filing →
SELL Nagendran Sukumar (President and Head of R&D)

26,918 shares @ $4.61

$124K

Jan 26, 2026

Conviction: | View SEC Filing →
SELL Alam Kamran (CHIEF FINANCIAL OFFICER)

23,849 shares @ $4.61

$110K

Jan 26, 2026

Conviction: | View SEC Filing →
SELL Nolan Sean P. (Chief Executive Officer)

136,789 shares @ $4.75

$650K

Jan 23, 2026

Conviction: | View SEC Filing →
SELL Nagendran Sukumar (President and Head of R&D)

89,132 shares @ $4.75

$423K

Jan 23, 2026

Conviction: | View SEC Filing →
SELL Alam Kamran (CHIEF FINANCIAL OFFICER)

78,968 shares @ $4.75

$375K

Jan 23, 2026

Conviction: | View SEC Filing →
SELL Nagendran Sukumar (President and Head of R&D)

200,000 shares @ $4.71

$942K

Jan 12, 2026

Conviction: | View SEC Filing →
SELL Nagendran Sukumar (President and Head of R&D)

260,047 shares @ $4.51

$1.17M

Dec 1, 2025

Conviction: | View SEC Filing →
SELL Nagendran Sukumar (President and Head of R&D)

110,125 shares @ $4.75

$523K

Nov 28, 2025

Conviction: | View SEC Filing →

⚠️ Important Disclaimer

• This is AI-generated analysis for educational purposes only, not financial advice.

• Insider trading data is derived from SEC Form 4 filings and may contain errors.

• Always conduct your own research and consult qualified financial advisors before making investment decisions.